dabigatran has been researched along with Alloxan Diabetes in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Fukuda, D; Kusunose, K; Rahadian, A; Salim, HM; Sata, M; Shimabukuro, M; Soeki, T; Yagi, S; Yamada, H | 1 |
| Chevalier, P; Dobreanu, D; FişcĂ, PC; Gherţescu, D; Huţanu, A; MĂrginean, A; Perian, M; Scridon, A; Şerban, RC; Vântu, A | 1 |
| Chevalier, P; Chinezu, L; Dobreanu, D; Fișcă, PC; Gheban, D; Gherțescu, D; Huțanu, A; Mărginean, A; Perian, M; Scridon, A; Șerban, RC; Vântu, A | 1 |
3 other study(ies) available for dabigatran and Alloxan Diabetes
| Article | Year |
|---|---|
Thrombin inhibition by dabigatran attenuates endothelial dysfunction in diabetic mice.
Topics: Animals; Antithrombins; Cells, Cultured; Dabigatran; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Endothelium, Vascular; Human Umbilical Vein Endothelial Cells; Humans; I-kappa B Kinase; Inflammation Mediators; Male; Mice, Inbred C57BL; Nitric Oxide Synthase Type III; Phosphorylation; Receptors, Proteinase-Activated | 2020 |
Plasma lipids affect dabigatran etexilate anticoagulation in rats with unbalanced diabetes mellitus.
Topics: Animals; Antithrombins; Blood Coagulation; Dabigatran; Diabetes Mellitus, Experimental; Lipids; Male; Rats; Rats, Wistar | 2018 |
Vascular protease-activated receptor 4 upregulation, increased platelet aggregation, and coronary lipid deposits induced by long-term dabigatran administration - results from a diabetes animal model.
Topics: Animals; Antithrombins; Aorta; Atherosclerosis; Coronary Vessels; Dabigatran; Diabetes Mellitus, Experimental; Drug Administration Schedule; Lipid Metabolism; Male; Plaque, Atherosclerotic; Platelet Aggregation; Rats, Wistar; Receptors, Thrombin; Time Factors; Up-Regulation | 2019 |